Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$122.0 - $145.31 $162,992 - $194,134
1,336 Added 22.08%
7,388 $956,000
Q2 2023

Aug 14, 2023

SELL
$122.5 - $147.16 $1.94 Million - $2.33 Million
-15,807 Reduced 72.31%
6,052 $750,000
Q1 2023

May 11, 2023

BUY
$133.98 - $160.47 $635,065 - $760,627
4,740 Added 27.69%
21,859 $3.2 Million
Q4 2022

Feb 07, 2023

BUY
$129.72 - $159.85 $2.22 Million - $2.74 Million
17,119 New
17,119 $2.73 Million
Q1 2022

May 06, 2022

SELL
$129.64 - $160.7 $697,592 - $864,726
-5,381 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$119.87 - $145.67 $645,020 - $783,850
5,381 New
5,381 $686,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Connectus Wealth, LLC Portfolio

Follow Connectus Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connectus Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connectus Wealth, LLC with notifications on news.